Tracy P B, Rohrbach M S, Mann K G
J Biol Chem. 1983 Jun 25;258(12):7264-7.
Isolated peripheral blood monocytes and lymphocytes interact with Factor Va and Factor Xa to form a functional catalytic complex which proteolytically activates prothrombin to thrombin. The kinetics of prothrombin activation were monitored continuously using the fluorescent, reversible thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide, which displays enhanced fluorescence upon binding to thrombin. Incubation of monocytes or lymphocytes with prothrombin, the cofactor (Factor Va), and the enzyme (Factor Xa) in the presence of Ca2+ generated thrombin at rates/cell exceeding those previously obtained with either bovine or human platelets. The rate of thrombin generation by monocytes exceeded that of lymphocytes and increased as monocytes adhered to a surface. Monocyte prothrombinase activity appears to be mediated through interactions, whereby Factor Va forms a receptor for Factor Xa at the monocyte surface. Monocytes possess approximately 16,100 Factor Va binding sites with a dissociation constant (Kd) of 4 X 10(-11) M. In addition, isolated, well washed monocytes and lymphocytes, respectively, contain approximately 61,400 +/- 9,900 and 24,500 +/- 4,800 molecules of Factor V/cell as determined by radioimmunoassay. Bioassay data of mononuclear cell preparations paralleled the radioimmunoassay data. The Factor V associated with washed mononuclear cells appears to be intracellular and not membrane-associated. The release of Factor V, and perhaps other sequestered coagulation factors, by these immunoreactive cells at an inflammatory site, coupled with the ability of these cells to effect thrombin generation may explain the relationship between extravascular fibrin deposition and mononuclear cell accumulation in the pathogenesis of inflammatory lesions.
分离出的外周血单核细胞和淋巴细胞与凝血因子Va和凝血因子Xa相互作用,形成一种功能性催化复合物,该复合物通过蛋白水解作用将凝血酶原激活为凝血酶。使用荧光、可逆的凝血酶抑制剂丹磺酰精氨酸N-(3-乙基-1,5-戊二醇)酰胺连续监测凝血酶原激活的动力学,该抑制剂与凝血酶结合后会显示出增强的荧光。在Ca2+存在的情况下,单核细胞或淋巴细胞与凝血酶原、辅因子(凝血因子Va)和酶(凝血因子Xa)一起孵育,产生凝血酶的速率/细胞超过了先前用牛或人血小板获得的速率。单核细胞产生凝血酶的速率超过淋巴细胞,并且随着单核细胞黏附于表面而增加。单核细胞凝血酶原酶活性似乎是通过相互作用介导的,即凝血因子Va在单核细胞表面形成凝血因子Xa的受体。单核细胞拥有约16,100个凝血因子Va结合位点,解离常数(Kd)为4×10(-11)M。此外,通过放射免疫测定法测定,分离并充分洗涤后的单核细胞和淋巴细胞分别含有约61,400±9,900和24,500±4,800个凝血因子V分子/细胞。单核细胞制备物的生物测定数据与放射免疫测定数据平行。与洗涤后的单核细胞相关的凝血因子V似乎是细胞内的,而不是膜相关的。这些免疫反应性细胞在炎症部位释放凝血因子V以及可能其他被隔离的凝血因子,再加上这些细胞产生凝血酶的能力,可能解释了炎症病变发病机制中血管外纤维蛋白沉积与单核细胞积聚之间的关系。